Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector

摘要: Disclosed is a nebulizable vaccine for transnasal administration, which has high prophylactic effect on human tuberculosis, particular adult tuberculosis. The tuberculosis administration comprises paramyxovirus gene (particularly rhPIV2) having, integrated therein, encoding an α-antigen derived from acid-fast bacterium (e.g., Mycobacterium kansaii or bovis BCG), analogue of the gene, variant equivalent function to that gene.